Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced that it is sponsoring a phase II clinical study of a vaccine against Clostridium difficile, which is among the most common causes of hospital-acquired infection in Europe and North America.
The details can be read here.
No comments:
Post a Comment